Global Losartan Potassium Tablets Market Size To Exceed USD 5.21 Billion By 2035 | CAGR of 6.3%
Category: HealthcareGlobal Losartan Potassium Tablets Market Size To Exceed USD 5.21 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Losartan Potassium Tablets Market Size is expected to grow from USD 2.66 Billion in 2024 to USD 5.21 Billion by 2035, at a CAGR of 6.3% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Losartan Potassium Tablets Market Size, Share, and COVID-19 Impact Analysis, By Strength (25 mg, 50 mg, and 100 mg), By Indication (Hypertension, Heart Failure, Chronic Kidney Disease, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. " Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/losartan-potassium-tablets-market
The losartan potassium tablets market involves the manufacturing and distribution of losartan potassium, a widely used angiotensin II receptor blocker (ARB) prescribed for managing high blood pressure, reducing stroke risk, and treating heart failure and kidney disorders. It works by relaxing blood vessels, improving blood flow, and lowering cardiovascular risk. Rising cases of hypertension and cardiovascular diseases globally are major growth drivers, as doctors increasingly prefer losartan for its proven safety and effectiveness. Additionally, a growing elderly population and heightened awareness of hypertension management support demand. Expanding opportunities arise from ongoing R&D focused on improving drug bioavailability and minimizing adverse effects. The availability of affordable generic versions further boosts market access, especially in emerging markets. Enhanced formulations improve compliance and treatment outcomes, making losartan a preferred choice, driving consistent market expansion. Elevated treatment expenses, adverse effects, stringent regulations, and poor patient compliance hinder market expansion.
The 50 mg segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on strength, the losartan potassium tablets market is divided into 25 mg, 50 mg, and 100 mg. Among these, the 50 mg segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. This dosage is widely regarded as effective for many patients and frequently recommended by doctors. Its adaptable dosing based on individual response and tolerance enhances its use, making it essential in managing hypertension.
The hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on indication, the losartan potassium tablets market is divided into hypertension, heart failure, chronic kidney disease, and others. Among these, the hypertension segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hypertension, a key contributor to cardiovascular diseases, forms the largest market segment. Its high prevalence and related complications require efficient treatment approaches, fueling the demand for antihypertensive drugs such as Losartan to manage and reduce associated health risks effectively.
North America is expected to hold the majority share of the global losartan potassium tablets market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global losartan potassium tablets market during the forecast period. The region benefits from robust government backing, widespread global awareness of hypertension management, and significant R&D investments by major pharmaceutical firms. With nearly half of U.S. adults affected by hypertension, there is a substantial demand for treatments such as Losartan.
Asia Pacific is anticipated to grow at the fastest pace in the global losartan potassium tablets market during the forecast period. Increasing hypertension and cardiovascular cases, along with an aging population, strongly boost demand. Improved healthcare awareness, infrastructure, government support, and favorable regulations further drive market expansion.
Major vendors in the global losartan potassium tablets market are Merck & Co., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Zydus Lifesciences Ltd., Sanofi S.A., Mylan N.V., Dr. Reddy's Laboratories, Lupin Limited, Novartis International AG, Aurobindo Pharma Limited, Torrent Pharmaceuticals, Sun Pharmaceutical Industries Limited, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In March 2025, Scienture Holdings announced FDA approval of SCN-102, branded Arbli, a 10 mg/mL losartan potassium oral suspension, providing a new liquid option for patients needing flexible dosing.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the losartan potassium tablets market based on the below-mentioned segments:
Global Losartan Potassium Tablets Market, By Strength
- 25 mg
- 50 mg
- 100 mg
Global Losartan Potassium Tablets Market, By Indication
- Hypertension
- Heart Failure
- Chronic Kidney Disease
- Others
Global Losartan Potassium Tablets Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?